disclosur
statement
je
schuster
noth
disclos
jv
william
serv
scientif
advisori
board
quidel
independ
data
monitor
committe
glaxosmithklin
respiratori
virus
lead
caus
pediatr
morbid
mortal
worldwid
last
year
molecular
detect
sequenc
led
increas
pathogen
identif
common
respiratori
ill
well
identif
pathogen
outbreak
scenario
heighten
awar
emerg
virus
necessari
provid
best
care
pediatr
patient
alert
public
health
offici
novel
diseas
season
influenza
gener
caus
yearli
epidem
variabl
preval
base
vaccin
efficaci
antigen
drift
antigen
drift
occur
season
influenza
due
minor
mutat
viral
hemagglutinin
h
neuraminidas
na
gene
antigen
shift
occur
abil
viru
infect
multipl
anim
especi
bird
abil
segment
genom
undergo
reassort
mix
differ
protein
differ
viral
strain
tabl
novel
influenza
strain
antigen
distinct
complet
exchang
gene
segment
encod
h
na
protein
introduc
h
na
variant
previous
circul
human
thu
reassort
virus
abil
caus
pandem
minim
preexist
popul
immun
avian
influenza
virus
pass
human
directli
close
contact
indirectli
anoth
anim
host
virus
adapt
bird
usual
limit
abil
replic
human
restrict
persontoperson
transmiss
howev
circumv
either
mutat
reassort
human
viru
pandem
reassort
avian
human
swine
influenza
virus
initi
report
novel
influenza
virus
center
case
human
case
occur
predominantli
southeast
asia
indian
subcontin
middl
east
howev
detect
bird
across
eurasia
indonesia
north
africa
newli
emerg
avian
influenza
strain
includ
identifi
patient
poultri
exposur
china
season
outbreak
human
occur
sinc
recent
spike
case
china
case
report
adult
influenza
caus
sever
diseas
higher
mortal
children
wherea
persontoperson
transmiss
common
nearli
half
pediatr
case
occur
secondari
cluster
novel
influenza
strain
retain
prefer
avian
receptor
well
adapt
humantohuman
transmiss
thu
pediatr
case
less
common
like
lower
rate
poultri
exposur
children
nonetheless
virus
adapt
control
set
transmiss
among
mammal
therefor
sustain
humantohuman
transmiss
could
possibl
place
children
risk
clinic
symptom
associ
novel
influenza
strain
similar
yearli
epidem
strain
howev
symptom
often
sever
due
lack
preexist
immun
sinc
reemerg
fatal
report
pediatr
case
describ
includ
symptom
consist
acut
enceph
compar
season
patient
higher
viral
load
exuber
cytokin
respons
mortal
approxim
cytopenia
andor
liver
involv
associ
sever
diseas
infect
human
first
report
china
three
patient
suffer
rapidli
progress
fatal
acut
respiratori
distress
syndrom
multiorgan
system
failur
known
recent
poultri
exposur
fever
cough
common
symptom
similar
laboratori
find
includ
cytopenia
elev
liver
function
test
elev
creatinin
kinas
fatal
case
novel
report
patient
recent
poultri
market
exposur
china
retrospect
test
demonstr
newli
emerg
viru
prior
evid
infect
poultri
worker
travel
histori
import
person
acut
respiratori
ill
novel
influenza
virus
occur
southeast
asia
although
influenza
detect
cell
cultur
molecular
diagnost
crucial
rapid
identif
novel
influenza
virus
revers
transcriptas
polymeras
chain
reaction
rtpcr
identifi
broad
rang
influenza
strain
subsequ
genom
sequenc
complet
identif
novel
strain
altern
rtpcr
primer
probe
specif
avian
h
na
gene
avail
wholeviru
influenza
vaccin
found
safe
pediatr
popul
good
antibodi
respons
h
na
compon
inactiv
vaccin
undergo
clinic
trial
viruslik
particl
vaccin
candid
effect
small
anim
model
oseltamivir
recommend
person
infect
novel
influenza
virus
although
report
resist
describ
chemoprophylaxi
oseltamivir
consid
base
exposur
risk
oseltamivir
chemoprophylaxi
recommend
highestrisk
exposur
group
ie
household
close
famili
member
contact
confirm
probabl
case
novel
influenza
consid
moderaterisk
exposur
group
ie
health
care
personnel
unprotect
close
contact
confirm
probabl
case
institut
appropri
isol
precaut
import
tabl
although
initi
identifi
influenza
c
member
orthomyxovirida
famili
less
well
describ
influenza
b
virus
influenza
c
viral
protein
contrast
viral
protein
influenza
b
respect
unlik
influenza
b
contain
na
outer
membran
protein
differ
contribut
uniqu
diseas
characterist
import
consider
tabl
isol
emerg
respiratori
virus
emerg
respiratori
virus
children
respect
antivir
treatment
similar
influenza
b
influenza
c
undergo
reassort
antigen
shift
contrast
influenza
influenza
c
exhibit
antigen
drift
multipl
variant
cocircul
see
tabl
data
suggest
viru
circul
global
like
respiratori
virus
infect
occur
earli
life
children
infect
less
year
old
influenza
c
rare
identifi
caus
medic
attend
ill
adult
preval
influenza
c
typic
less
influenza
approach
influenza
b
year
although
overal
rate
low
less
respiratori
specimen
one
studi
epidem
occur
conjunct
replac
domin
antigen
group
influenza
c
circul
primarili
winter
earli
summer
recent
studi
use
molecular
detect
suggest
influenza
c
frequent
children
previous
recogn
clinic
symptom
influenza
c
symptom
indistinguish
influenza
b
one
cohort
almost
onefifth
children
influenza
c
predominantli
less
year
old
hospit
primarili
due
pneumonia
bronchiol
ambulatori
set
upper
respiratori
tract
infect
common
fever
cough
common
symptom
group
influenza
c
identifi
caus
hospit
pediatr
communityacquir
pneumonia
influenza
c
associ
fewer
febril
day
less
health
care
util
influenza
b
suggest
milder
pathogen
like
influenza
type
influenza
c
associ
encephalopathi
rtpcr
method
use
identifi
influenza
c
viral
cultur
difficult
limit
cell
cultur
method
furthermor
viru
display
easili
distinguish
strong
cytopath
effect
like
influenza
b
treatment
influenza
c
well
describ
neuraminidas
inhibitor
ineffect
lack
na
glycoprotein
outer
membran
viru
vitro
data
suggest
amantadin
activ
influenza
c
howev
adamantan
broad
toxic
routin
recommend
high
rate
resist
influenza
current
licens
season
influenza
vaccin
contain
antigen
influenza
c
protect
support
care
recommend
droplet
isol
use
children
hospit
influenza
c
infect
see
tabl
coronavirus
cov
common
caus
pediatr
respiratori
tract
diseas
account
common
cold
virus
classifi
differ
genera
alpha
beta
gamma
deltacoronaviru
cov
infect
multipl
speci
crossov
anim
human
lead
outbreak
epidem
cov
report
notabl
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
saudi
arabian
present
pneumonia
respiratori
failur
novel
betacoronaviru
subsequ
term
middl
east
respiratori
syndrom
merscov
identifi
although
case
detect
saudi
arabia
unit
arab
emir
import
case
unit
state
describ
viru
close
relat
bat
cov
howev
camel
later
identifi
intermediari
host
zoonot
transmiss
occur
merscov
seropreval
significantli
higher
among
person
camel
exposur
persontoperson
transmiss
occur
led
secondari
hospit
outbreak
although
initi
report
primarili
occur
adult
like
relat
zoonot
occup
exposur
pediatr
case
develop
household
contact
case
descript
patient
merscov
primarili
adult
patient
hospit
sarscov
one
case
seri
fever
present
symptomat
patient
cough
present
upper
respiratori
tract
symptom
less
common
subject
rhinorrhea
gastrointestin
symptom
includ
diarrhea
report
although
initi
case
fatal
rate
exceed
larg
number
patient
laboratoryconfirm
infect
asymptomat
studi
data
spars
children
one
case
seri
saudi
children
confirm
merscov
median
age
year
rang
year
older
respiratori
virus
patient
symptom
underli
medic
diseas
cystic
fibrosi
syndrom
cardiopulmonari
diseas
although
younger
child
die
respiratori
failur
older
child
rel
uncompl
hospit
cours
pulmonari
imag
children
demonstr
bilater
diffus
infiltr
one
cohort
household
contact
merscovinfect
subject
secondari
attack
rate
rel
low
viru
increas
predilect
children
none
infect
children
develop
symptom
suggest
diseas
may
wors
primari
transmiss
andor
adult
novel
influenza
virus
travel
exposur
histori
import
realtim
rtpcr
avail
diagnosi
merscov
serolog
test
also
exist
viral
cultur
perform
requir
proper
specimen
handl
biosafeti
facil
merscovspecif
treatment
exist
small
retrospect
studi
adult
sever
merscov
patient
treat
oral
ribavirin
subcutan
pegyl
interferon
improv
surviv
day
vs
howev
surviv
significantli
differ
vs
candid
vaccin
studi
howev
preclin
stage
airborn
contact
precaut
recommend
prevent
persontoperson
transmiss
see
tabl
human
rhinovirus
rv
member
picornavirida
famili
lead
caus
respiratori
ill
children
new
rv
speci
distinct
speci
b
identifi
sequenc
viral
protein
region
specimen
children
hospit
respiratori
ill
corrobor
discoveri
new
speci
rhinoviru
c
rvc
children
isol
identifi
hospit
asthma
febril
wheez
sixti
genotyp
rvc
identifi
global
burden
rvc
signific
approxim
onequart
rv
infect
attribut
rvc
rate
rvc
gener
higher
emerg
respiratori
virus
children
rvb
compar
rva
studi
rvc
detect
yearround
clinic
symptom
although
rv
detect
symptomat
asymptomat
children
rvc
commonli
associ
episod
clinic
ill
rvc
detect
healthi
children
rvc
caus
sever
respiratori
diseas
particularli
asthmat
associ
asthma
exacerb
children
casecontrol
studi
children
rvc
like
requir
supplement
oxygen
wheez
children
rva
howev
studi
rva
rvc
produc
similar
clinic
symptom
one
case
seri
rvcinfect
hospit
children
requir
supplement
oxygen
wheez
rvcinfect
children
outpati
emerg
depart
set
like
radiograph
confirmedclin
diagnos
lower
respiratori
tract
ill
eg
bronchiol
pneumonia
croup
asthma
compar
children
rv
addit
children
rvcrelat
wheez
like
hospit
respiratori
problem
compar
nonrv
respiratori
virus
diagnosi
rv
typic
detect
nasopharyng
specimen
use
rtpcr
broad
rang
pcr
allow
detect
varieti
rv
use
primer
target
conserv
region
subsequ
step
includ
seminest
pcr
sequenc
identifi
specif
speci
serotyp
rvc
also
detect
stool
well
blood
higher
rate
viremia
occur
rvc
compar
rv
type
rv
detect
use
cell
cultur
howev
method
highli
variabl
depend
optim
temperatur
c
motion
time
day
see
cytopath
effect
furthermor
rvc
extrem
difficult
cultur
requir
highli
special
method
antigen
antibodi
detect
hamper
presenc
numer
rv
serotyp
licens
treatment
rvc
exist
experiment
antivir
vitro
efficaci
rvc
although
notabl
pleconaril
activ
rv
vaccin
develop
complic
numer
viral
serotyp
lack
crossserotyp
protect
droplet
isol
use
children
hospit
clinic
appar
rvc
infect
respiratori
virus
remain
lead
caus
childhood
diseas
identif
emerg
novel
respiratori
virus
import
pediatrician
infecti
diseas
clinician
virus
previous
difficult
cultur
rapidli
identifi
use
molecular
diagnost
sequenc
techniqu
highli
use
detect
outbreak
addit
ongo
evolut
virus
abil
mutat
allow
speciestospeci
transmiss
novel
virus
practition
remain
high
alert
emerg
virus
case
wherebi
caus
identifi
clinic
syndrom
clinic
syndrom
sever
expect
identifi
pathogen
travel
anim
exposur
histori
import
maintain
high
index
suspicion
rapid
institut
appropri
isol
precaut
crucial
prevent
persontoperson
transmiss
see
tabl
